PEOPLE - Live Tissue Connect makes appointment:
This article was originally published in Clinica
Frank D'Amelio, former chief technology officer of Gyrus Group (visualisation and tissue management systems/instruments), has joined wound closure device manufacturer Live Tissue Connect, whose products are due to enter the European markets during the first quarter of the year. The firm is a subsidiary of CSMG Technologies (Corpus Christi, Texas), a technology management company that focuses on technologies developed in the Ukraine.
You may also be interested in...
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.